Previous studies have indicated that the majority of newly diagnosed breast cancer patients at high risk of being BRCA1/2 mutation carriers will accept the invitation to undergo RGCT, and that the DNA test results can have a substantial impact on the choice of surgery [3,24,25]. Here, BRCA1 is linked to breast cancer.